Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS])

de Boer, Rudolf A, Doehner, Wolfram, van der Horst, Iwan C C, Anker, Stefan D, Babalis, Daphne, Roughton, Michael, Coats, Andrew J, Flather, Marcus D and van Veldhuisen, Dirk J and SENIORS Investigators (2010) Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]). The American Journal of Cardiology, 106 (1). 78-86.e1. ISSN 1879-1913

Full text not available from this repository. (Request a copy)

Abstract

The beneficial effects of beta blockers in younger patients with heart failure (HF) due to systolic dysfunction are well established. However, data from patients > or =70 years old with diabetes mellitus and HF are lacking. The Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS] tested the efficacy of the vasodilator beta blocker nebivolol in patients > or =70 years old with HF and impaired or preserved left ventricular ejection fraction. In the present analysis, we evaluated the association between diabetes mellitus and baseline glucose levels on the primary outcome (all-cause mortality and cardiovascular hospitalization) and secondary end points, including all-cause mortality, cardiovascular hospitalizations, and cardiovascular mortality. Of 2,128 patients, 555 (26.1%) had diabetes mellitus. Of the 555 patients with diabetes mellitus, 223 (40.2%) experienced the primary end point compared to 484 (30.8%) of the 1,573 nondiabetic patients (p or =70 years old with HF, diabetes mellitus was associated with a worse prognosis. Nebivolol was less effective in the patients with diabetes and HF than in those with HF but without diabetes who were > or =70 years old.

Item Type:	Article
Additional Information:	Copyright (c) 2010 Elsevier Inc. All rights reserved.
Uncontrolled Keywords:	adrenergic beta-antagonists,aged,aged, 80 and over,benzopyrans,diabetes mellitus,diabetic angiopathies,ethanolamines,female,heart failure,hospitalization,humans,hyperglycemia,male,prognosis,treatment outcome,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Depositing User:	Danelle Breach
Date Deposited:	31 Mar 2011 12:07
Last Modified:	22 Dec 2022 11:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/27791
DOI:	10.1016/j.amjcard.2010.02.018

Actions (login required)

View Item